Purchase Order 75D30123P15844
- Not listed
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $159,300.00 firm fixed price purchase order to Life Technologies Corporation, a for-profit provider of biomedical research and genetic analysis tools and technologies. The contract, which does not have a set-aside designation, is for the delivery of specialized gene expression products and services, including "TAC CARDS", to support the CDC's disease research, healthcare programs, and...
- This is a federal contract awarded by the National Cancer Institute (NCI), a component of the Department of Health and Human Services (HHS), to Asuragen Incorporated, a small business. The contract is for the development and supply of a BCR-ABL 1 RT-QPCR test to improve monitoring of chronic myeloid leukemia (CML). This is a Phase II Small Business Innovation Research (SBIR) contract with a ceiling value of $1,489,494.00. The contract is a definitive contract with a cost-plus-fixed-fee pricing...
- This firm fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $85,056.40 contract is for the delivery of laboratory reagents, with an ultimate completion date of July 31, 2022. The contract does not have a set-aside designation. Illumina has previously received federal prime contract and subcontract awards from agencies like the National...
- This $151,410.00 firm fixed price purchase order was awarded to XCR Diagnostics, Inc., a manufacturer of molecular diagnostics testing products, by the Centers for Disease Control and Prevention (CDC) out of Pittsburgh, Pennsylvania. The contract is for the delivery of laboratory supplies including CBOT singleplex assays, which are used for disease diagnostic testing. This purchase order is not associated with any larger contract vehicle and does not have a set-aside designation. XCR...
- This federal contract award was made by the Department of Health and Human Services Centers for Disease Control and Prevention to Life Technologies Corporation, a for-profit provider of laboratory equipment and technologies for biomedical research and genetic analysis. The $118,049.95 firm fixed-price purchase order is for the delivery of unspecified laboratory equipment. The contract has no set-aside designation and was awarded on August 22, 2017, with a completion date of August 29, 2018. As a...
- This is a firm-fixed-price purchase order contract awarded by the Air Education and Training Command (AETC), a defense agency, to Advanced Cell Diagnostics, Inc. (ACD), a for-profit manufacturer of goods. The contract, valued at $89,998.11, is for the provision of RNA SCOPE LS MULTIPLEX FLORESCENT products and services. ACD is a subsidiary of Bio-Techne Corporation and specializes in advanced RNA detection technologies, primarily serving various National Institutes of Health (NIH) agencies...
- This firm-fixed-price purchase order was awarded by the Office of Logistics and Acquisition Operations, a civilian agency, to Advanced Cell Diagnostics, Inc. (ACD) on September 18, 2020. The $19,999.60 award has an ultimate completion date of September 30, 2021 and does not have a set-aside designation. ACD, a subsidiary of Bio-Techne Corporation, is a molecular diagnostics company that specializes in RNA detection technologies, particularly its proprietary RNAscope platform. The company has...
- This federal contract award to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables, is for the procurement of WALLER TAQMAN ARRAY CARDS. The $150,049.95 firm-fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh office, a civilian agency, with a performance location in Carlsbad, CA. The contract has an ultimate completion date of November 8, 2024 and does not utilize a set-aside. Life...
- This federal contract award, valued at $97,350.00, was issued by the Centers for Disease Control and Prevention (CDC) to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific. The contract is for the delivery of "SPECIAL GENE EX CONF4 TAC CARDS" and is a Blanket Purchase Agreement (BPA) Call, with a firm fixed price pricing type. The contract has no set-aside designation. Life Technologies Corporation is a manufacturer of scientific instruments, reagents, and...
- This federal contract award was made by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) in Pittsburgh, PA to Life Technologies Corporation, a for-profit organization. The $153,549.95 firm fixed-price purchase order is for the delivery of LUMINEX XMAP INTELLIFLEX DRSE products, with a completion date of September 30, 2021. Life Technologies Corporation is a subsidiary of Thermo Electron Corporation, another for-profit manufacturer that has previously...
This federal contract award, with an ID of 75D30123P15844, was issued by the Centers for Disease Control and Prevention (CDC) to Asuragen Incorporated, a molecular diagnostics company. The $75,075.00 firm fixed-price purchase order is for ARMORED RNA products, which are reagents and testing materials compatible with specialized medical equipment used for cancer and leukemia testing at government healthcare facilities. Asuragen, a subsidiary of the life sciences company Bio-Techne Corporation, has a history of providing reagents, kits, and testing materials to the Department of Defense, Veterans Affairs, and Department of Health and Human Services through various prime contract awards. These contracts, which include no set-aside designations, have supported the use of Asuragen's Quantidex PCR reagents, Armored RNA, and BCR ABL reagents with Applied Biosystems instrumentation at government medical centers. The current award has a performance period ending on December 23, 2022.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $75.1k | 12/1/22 |